INS and type 2 diabetes mellitus: At present, insulin, metformin, α-glucosidase inhibitors, thiazolidinediones, glucagonlike peptide–based therapy, dipeptidyl peptidase 4 inhibitors, and sodium-glucose transport protein 2 (SGLT-2) inhibitors have been clinical used in the treatment of T2DM [5].